Update on Risk of Endophthalmitis After Intravitreal Drug Injections and Potential Impact of Elimination of Topical Antibiotics

Authors:

1 June 2012

journal article
letter
Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)

Vol. 130 (6) , 809-810
DOI:10.1001/archophthalmol.2012.227
PMID:22801859
PMCID:PMC3489025

Abstract

Previously, the Diabetic Retinopathy Clinical Research Network reported a low rate of endophthalmitis achieved after intravitreal injection via a protocol requi

Keywords

ANTIBIOTICS PREVIOUSLY
POTENTIAL IMPACT
TOPICAL ANTIBIOTICS
DIABETIC RETINOPATHY
RETINOPATHY CLINICAL
CLINICAL RESEARCH
RESEARCH NETWORK
INTRAVITREAL DRUG
DRUG INJECTIONS
NETWORK REPORTED

This publication has 4 references indexed in Scilit:

RANDOMIZED TRIAL EVALUATING SHORT-TERM EFFECTS OF INTRAVITREAL RANIBIZUMAB OR TRIAMCINOLONE ACETONIDE ON MACULAR EDEMA AFTER FOCAL/GRID LASER FOR DIABETIC MACULAR EDEMA IN EYES ALSO RECEIVING PANRETINAL PHOTOCOAGULATION
Retina, 2011
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Ophthalmology, 2010
Risk of Endophthalmitis After Intravitreal Drug Injection When Topical Antibiotics Are Not Required
Archives of Ophthalmology (1950), 2009
A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema
Ophthalmology, 2007